Canopy Growth Corporation (CGC)

CIK 0001737927 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-08-07) · 99.1  |  8-K (2025-08-08) · 99.1
Latest FY-2026 8-K (2026-06-15) · 99.1
Q3-2026 8-K (2026-02-06) · 99.1
Q2-2026 8-K (2025-11-07) · 99.1
Q1-2026 8-K (2026-08-07) · 99.1  |  8-K (2025-08-08) · 99.1
FY-2025 8-K (2025-05-30) · 99.1
Q3-2025 8-K (2025-02-07) · 99.1
Q2-2025 8-K (2024-11-08) · 99.1
Q1-2024 8-K (2024-08-09) · 99.1
FY-2024 8-K (2024-05-30) · 99.1
Q3-2023 8-K (2024-02-09) · 99.1  |  8-K (2023-02-09) · 99.1
Q2-2023 8-K (2023-11-09) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Condensed Interim Consolidated Balance Sheets (unaudited)
—
Consolidated Balance Sheets
—
Condensed Interim Consolidated Balance Sheets (P) (unaudited)
—
Consolidated Balance Sheets (P)
—
Condensed Interim Consolidated Statements of Operations and Comprehensive Income (loss) (unaudited)
—
Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (unaudited)
—
Consolidated Statements of Operations and Comprehensive Loss
—
Condensed Interim Consolidated Statements of Shareholder's Equity (unaudited)
—
Consolidated Statements of Shareholders' Equity
—
Condensed Interim Consolidated Statements of Cash Flows (unaudited)
—
Consolidated Statements of Cash Flows
—
Condensed Interim Consolidated Statements of Cash Flows (P) (unaudited)
—
Consolidated Statements of Cash Flows (P)
—
Notes
(gain)/loss On Asset Impairment and Restructuring
—
Accumulated Other Comprehensive Income (loss)
Acquisitions
—
Acreage Arrangement
Acreage Arrangement and Amendments To Cbi Investor Rights Agreement and Warrants
Amounts Receivable, Net
Asset Impairment and Restructuring Costs
—
Award Timing Disclosure
—
Basis of Presentation
Biosteel
Canopy Usa
Cash and Cash Equivalents
Commitments and Contingencies
Cybersecurity Risk Management, Strategy, and Governance
—
Debt
Description of Business
Divestitures
—
Equity Method Investments
—
Fair Value of Financial Instruments
Goodwill
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Assets
Inventory
Leases
—
Loss On Asset Impairment and Restructuring
—
New Accounting Policies
—
Noncontrolling Interests
Other Accrued Expenses and Liabilities
Other Financial Assets
Other Income (expense), Net
Other Investments
Other Liabilities
Pay Vs Performance Disclosure
Prepaid Expenses and Other Assets
Property, Plant and Equipment
Recovery of Erroneously Awarded Compensation
—
Redeemable Noncontrolling Interest
Related Party
—
Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements (unaudited)
—
Retail Divestiture
—
Revenue
Segment Information
—
Segmented Information
—
Share Capital
Share-based Compensation
Short-term Investments
Subsequent Events
Summary of Significant Accounting Policies
—
This Works Divestiture
—